antibacterial agent 18

Antibacterial agent 18 is a multi-arm AIE molecule with antibacterial activity, inhibiting the growth of both gram-positive and gram-negative bacteria by disrupting glycosylation and transpeptidation processes, affecting bacterial cell wall synthesis, useful for studying bacterial infections.

Antibacterialagent 185 (compound IP-01) is a potent antibacterial agent. It inhibits the polymerization and bundling of filamentous temperature-sensitive mutant Z (FtsZ) by enhancing GTP hydrolysis. Antibacterialagent 185 is effective against Streptococcus pneumoniae and displays a narrow spectrum of activity.

Antibacterialagent 181 (Compound 3f) is an effective cationic antibacterialagent (antibacterialagent) with low cytotoxicity. It exhibits a minimum inhibitory concentration (MIC) of 2 μg/mL against both Staphylococcus aureus and Escherichia coli.

Antibacterialagent 182 (compound 8c) is an antibacterial agent that exhibits activity against various Gram-positive bacteria, particularly displaying efficacy against vancomycin-resistant Enterococcus faecium (MIC ≤0.125 μg/mL). At sub-MIC levels, Antibacterialagent 182 can inhibit biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa.

Antibacterialagent 186 (compound 25) is a potent antibacterial agent that demonstrates anti-biofilm formation properties against clinical strains of Staphylococcus epidermidis and has the capability to eradicate existing biofilms. It also holds potential for studying multidrug-resistant strains of Staphylococcus epidermidis.

Antibacterialagent 187 (IKE7) is a derivative containing imidazole and triazolacridinone structures, designed to target yeast topoisomerase II. It exhibits antifungal activity with minimum inhibitory concentration (MIC) values ranging from 32 to 64 μg/mL against fluconazole-resistant strains.

Antibacterialagent 180 (15g) is a substrate for type I nitroreductase (TcNTR I) and serves as a potential antitrypanosomal drug. It demonstrates non-mutagenic properties against Salmonella typhimurium strains (TA98, TA100, and TA102).

Antibacterialagent 184 (compound 4j) is a fungicide with demonstrated toxicity against the plant pathogenic fungus Sclerotinia sclerotiorum. It effectively inhibits Sclerotinia sclerotiorum with an inhibition rate (IR) exceeding 97%.

Antibacterialagent 189 (compound 3a) is a potent antibacterial agent with high binding affinity to the target proteins OMPA/exo-1,3-β-glucanase. It demonstrates effective antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Bacillus subtilis, Candida albicans, and Aspergillus flavus. Additionally, Antibacterialagent 189 exhibits strong binding affinity to the target proteins SMO and SUFU/GLI-1.

Compound 2d (Antibacterial agent 188) serves as an antibacterial agent that suppresses the activity of dermatophytes [1].

Berberine chloride (Natural Yellow 18) is an alkaloid derived from Hydrastis canadensis L. of the Berberidaceae family, serving as a commonly used intestinal antibacterial agent. Berberine chloride exhibits biological activities including anti-inflammatory, hypoglycemic, lipid-regulating, antitumor, and cardiovascular protective effects. Berberine chloride can be utilized in research on chronic diseases and tumors.

Antibacterial agent 52 (example 18) is an antibacterial agent.

Compound 5k (Antiproliferative Agent-18) is an antiproliferative agent that exhibits moderate antibacterial and antifungal activities [1].